237 related articles for article (PubMed ID: 29511337)
1. Post-translational modification of OCT4 in breast cancer tumorigenesis.
Cho Y; Kang HG; Kim SJ; Lee S; Jee S; Ahn SG; Kang MJ; Song JS; Chung JY; Yi EC; Chun KH
Cell Death Differ; 2018 Nov; 25(10):1781-1795. PubMed ID: 29511337
[TBL] [Abstract][Full Text] [Related]
2. Carboxy terminus of HSP70-interacting protein (CHIP) attenuates the stemness of thyroid cancer cells through decreasing OCT4 protein stability.
Xu Y; Xu G; Dang H; Qu W; Chang D; He X; Li M; Wang Q
Environ Toxicol; 2021 Apr; 36(4):686-693. PubMed ID: 33270330
[TBL] [Abstract][Full Text] [Related]
3. The E3 ubiquitin ligase CHIP selectively regulates mutant epidermal growth factor receptor by ubiquitination and degradation.
Chung C; Yoo G; Kim T; Lee D; Lee CS; Cha HR; Park YH; Moon JY; Jung SS; Kim JO; Lee JC; Kim SY; Park HS; Park M; Park DI; Lim DS; Jang KW; Lee JE
Biochem Biophys Res Commun; 2016 Oct; 479(2):152-158. PubMed ID: 27475501
[TBL] [Abstract][Full Text] [Related]
4. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.
Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH
Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162
[TBL] [Abstract][Full Text] [Related]
5. The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5.
Zhang HT; Zeng LF; He QY; Tao WA; Zha ZG; Hu CD
Biochim Biophys Acta; 2016 Feb; 1863(2):335-46. PubMed ID: 26658161
[TBL] [Abstract][Full Text] [Related]
6. C-Terminus of Hsc70-interacting protein regulates profilin1 and breast cancer cell migration.
Choi YN; Lee SK; Seo TW; Lee JS; Yoo SJ
Biochem Biophys Res Commun; 2014 Apr; 446(4):1060-6. PubMed ID: 24661873
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin ligase CHIP induces TRAF2 proteasomal degradation and NF-κB inactivation to regulate breast cancer cell invasion.
Jang KW; Lee KH; Kim SH; Jin T; Choi EY; Jeon HJ; Kim E; Han YS; Chung JH
J Cell Biochem; 2011 Dec; 112(12):3612-20. PubMed ID: 21793045
[TBL] [Abstract][Full Text] [Related]
8. RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.
Yang YL; Zhang Y; Li DD; Zhang FL; Liu HY; Liao XH; Xie HY; Lu Q; Zhang L; Hong Q; Dong WJ; Li DQ; Shao ZM
Cell Death Differ; 2020 Mar; 27(3):1105-1118. PubMed ID: 31406303
[TBL] [Abstract][Full Text] [Related]
9. [Effect of down-regulation of Oct4 gene on biological characteristics of MDA-MB-231 breast cancer stem cells].
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):251-7. PubMed ID: 26462888
[TBL] [Abstract][Full Text] [Related]
10. Stability of the cancer target DDIAS is regulated by the CHIP/HSP70 pathway in lung cancer cells.
Won KJ; Im JY; Kim BK; Ban HS; Jung YJ; Jung KE; Won M
Cell Death Dis; 2017 Jan; 8(1):e2554. PubMed ID: 28079882
[TBL] [Abstract][Full Text] [Related]
11. Wwp2 mediates Oct4 ubiquitination and its own auto-ubiquitination in a dosage-dependent manner.
Liao B; Jin Y
Cell Res; 2010 Mar; 20(3):332-44. PubMed ID: 19997087
[TBL] [Abstract][Full Text] [Related]
12. CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha.
Fan M; Park A; Nephew KP
Mol Endocrinol; 2005 Dec; 19(12):2901-14. PubMed ID: 16037132
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
Kar S; Patra SK
Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
[TBL] [Abstract][Full Text] [Related]
14. 2-(4-Hydroxy-3-methoxyphenyl)-benzothiazole suppresses tumor progression and metastatic potential of breast cancer cells by inducing ubiquitin ligase CHIP.
Hiyoshi H; Goto N; Tsuchiya M; Iida K; Nakajima Y; Hirata N; Kanda Y; Nagasawa K; Yanagisawa J
Sci Rep; 2014 Nov; 4():7095. PubMed ID: 25403352
[TBL] [Abstract][Full Text] [Related]
15. CHIP-mediated degradation of transglutaminase 2 negatively regulates tumor growth and angiogenesis in renal cancer.
Min B; Park H; Lee S; Li Y; Choi JM; Lee JY; Kim J; Choi YD; Kwon YG; Lee HW; Bae SC; Yun CO; Chung KC
Oncogene; 2016 Jul; 35(28):3718-28. PubMed ID: 26568304
[TBL] [Abstract][Full Text] [Related]
16. Regulation of fragile X mental retardation 1 protein by C-terminus of Hsc70-interacting protein depends on its phosphorylation status.
Choi YN; Jeong DH; Lee JS; Yoo SJ
Biochem Biophys Res Commun; 2014 Oct; 453(1):192-7. PubMed ID: 25268320
[TBL] [Abstract][Full Text] [Related]
17. RNF144A suppresses ovarian cancer stem cell properties and tumor progression through regulation of LIN28B degradation via the ubiquitin-proteasome pathway.
Li Y; Wang J; Wang F; Chen W; Gao C; Wang J
Cell Biol Toxicol; 2022 Oct; 38(5):809-824. PubMed ID: 33978933
[TBL] [Abstract][Full Text] [Related]
18. Itch, an E3 ligase of Oct4, is required for embryonic stem cell self-renewal and pluripotency induction.
Liao B; Zhong X; Xu H; Xiao F; Fang Z; Gu J; Chen Y; Zhao Y; Jin Y
J Cell Physiol; 2013 Jul; 228(7):1443-51. PubMed ID: 23255053
[TBL] [Abstract][Full Text] [Related]
19. WWP2 promotes degradation of transcription factor OCT4 in human embryonic stem cells.
Xu H; Wang W; Li C; Yu H; Yang A; Wang B; Jin Y
Cell Res; 2009 May; 19(5):561-73. PubMed ID: 19274063
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin ligase CHIP suppresses cancer stem cell properties in a population of breast cancer cells.
Tsuchiya M; Nakajima Y; Hirata N; Morishita T; Kishimoto H; Kanda Y; Kimura K
Biochem Biophys Res Commun; 2014 Oct; 452(4):928-32. PubMed ID: 25234599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
